← Back to Search

Problem-Solving Therapy for Caregiver Stress

N/A

Waitlist Available

Led By Karla Washington, Ph.D.

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must be 18 years of age or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the time of enrollment, week 4, and 30-day follow-up

Awards & highlights

Study Summary

This trial is testing a problem-solving therapy intervention for family caregivers of cancer patients receiving outpatient palliative care.

Who is the study for?

This trial is for unpaid family caregivers of cancer patients receiving outpatient palliative care, regardless of legal or biological relationship. Participants must be over 18 and involved in the patient's care at one of the clinical sites. They need to consent to join the study.Check my eligibility

What is being tested?

The study tests problem-solving therapy for these caregivers, comparing it with an attention-matched control group. Caregivers are randomly assigned to either receive this specific therapy or participate in interviews that match for time and attention but don't include therapeutic intervention.See study design

What are the potential side effects?

Since this trial involves psychological therapy rather than medication, traditional side effects like those seen with drugs aren't expected. However, participants may experience emotional discomfort discussing personal issues during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the time of enrollment, week 4, and 30-day follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the time of enrollment, week 4, and 30-day follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the time of enrollment, week 4, and 30-day follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in anxiety as measured by the PROMIS Short Form v1.0 - Anxiety 8a

Change in symptoms of depression as measured by the PROMIS Short Form v1.0 - Depression 8a

Secondary outcome measures

Change in positive aspects of caregiving as measured by Positive Aspects of Caregiving Scale - Short Form (S-PAC; 7 items)

Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Problem Solving Therapy InterventionExperimental Treatment1 Intervention

Family caregivers in the intervention study arm will participate in three problem-solving therapy sessions with a trained interventionist in addition to receiving the services and support provided as part of usual outpatient palliative care.

Group II: In-Depth Interviews for non-FCG StakeholdersExperimental Treatment1 Intervention

Each year of the project, the investigators will recruit 6 key stakeholders to participate in individual interviews focused on potential barriers and facilitators to adoption of the PST intervention into clinical practice for a total of 30 unique stakeholders who will be interviewed over the duration of this 5-year study.

Group III: Attention ControlPlacebo Group1 Intervention

Family caregivers in the attention control study arm will receive three sessions of attention-matched control in addition to the services and support provided as part of usual outpatient palliative care. Attention-matched control will consist of three "friendly visits" with a trained research staff person.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Problem-Solving Therapy

2019

Completed Phase 4

~880

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaOTHER

361 Previous Clinical Trials

627,464 Total Patients Enrolled

1 Trials studying Palliative Care

83 Patients Enrolled for Palliative Care

Washington University School of MedicineLead Sponsor

1,933 Previous Clinical Trials

2,299,195 Total Patients Enrolled

1 Trials studying Palliative Care

242 Patients Enrolled for Palliative Care

University of PennsylvaniaOTHER

2,000 Previous Clinical Trials

42,879,558 Total Patients Enrolled

3 Trials studying Palliative Care

16,745 Patients Enrolled for Palliative Care

Media Library

Problem-Solving Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04867122 — N/A

Palliative Care Research Study Groups: Attention Control, Problem Solving Therapy Intervention, In-Depth Interviews for non-FCG Stakeholders

Palliative Care Clinical Trial 2023: Problem-Solving Therapy Highlights & Side Effects. Trial Name: NCT04867122 — N/A

Problem-Solving Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04867122 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor currently in need of participants?

"This particular trial, which was first posted on January 24th 2022 and recently updated in August 15th of the same year, is not currently recruiting. However, there are 1,715 other clinical trials actively seeking participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care

2022. "Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04867122.